OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) shares plunged more than 48% pre-market after the company said results from its Phase 3 SYNERGY trial to add custirsen to standard first-line treatment of docetaxel/prednisone in men with metastatic prostate cancer failed to meet primary endpoints. The stock which was halted from trading ahead of the news, recently changed hands…
Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Acasti Pharma Inc (NASDAQ:ACST), a Neptune subsidiary, Sunday night announced that a final and binding patent infringement settlement and license agreement has been signed with Enzymotec Ltd. and Enzymotec Ltd(NASDAQ:ENZY) that resolves the International Trade Commission’s investigation of infringement of Neptune’s composition of matter patents, related federal court actions initiated by…
The American Despositary Receipts of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) edged up in recent pre-market trading on Monday after announcing over the weekend an agreement it has signed with Takeda Pharmaceutical for the marketing and sale of Rasagiline in Japan. Rasagiline is a treatment for Parkinson’s Disease developed by TEVA and has been approved in…
Apple Inc.(NASDAQ:AAPL) is offering a program to replace faulty iPhone 5 sleep/wake buttons free of charge, the Wall Street Journal reports. The program is being offered for iPhone 5 handsets built before April 2013. Analysts have a consensus price target of $593 on Apple Inc.(NASDAQ:AAPL) which indicates a 14% upside. The consensus rating of the stock…
Shares of AstraZeneca plc (ADR)(NYSE:AZN) reached a new high in pre-market trading as Pfizer Inc.(NYSE:PFE) confirmed it has attempted to renew negotiations on a possible merger. Pfizer submitted a preliminary indication of interest to the board of directors of AstraZeneca in January 2014 regarding the possible merger. AstraZeneca declined to pursue negotiations at that time, but…
Apple (NASDAQ AAPL) is a stock which has really outperformed other stocks in 2015. The stock has not put a foot wrong and has consistently grown. Apple is currently trading at $125 levels. Before the launch of iPhone 6, the stock was trading below the levels of $100. Some major analysts have predicted the levels…
Tech Analysis & Market News